2172 — Microport NeuroTech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual cashflow statement for Microport NeuroTech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	52.4	51.4	31.9	-4.33	162
Depreciation
Non-Cash Items	2.73	4.22	40	135	55.5
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-7.75	-20.9	53.8	36	-120
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	56.6	47.2	157	224	154
Capital Expenditures	-50.1	-34.1	-58	-47.9	-42.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.272	-38.9	-129	-297	-191
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-49.8	-73	-187	-345	-233
Financing Cash Flow Items	-2.68	148	-115	79	-0.93
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	9.66	432	201	330	-33.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	16.5	403	168	235	-107